[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:crohn-disease":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":309,"states":310},"Crohn Disease",136,103,[8,16,23,29,35,41,47,53,60,66,72,78,84,90,96,103,109,115,120,125,131,137,143,149,155,161,167,173,179,185,191,197,204,210,216,222,228,234,240,246,252,258,264,269,275,281,287,292,298,304],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06227910","A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease",[12],"Phase 3","RECRUITING","2026-08-26T02:16:59.895916Z","2026-07-05T05:32:16.746236Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06918808","DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease",[20],"Phase 2","2026-08-26T02:15:58.452248Z","2026-07-05T05:32:16.703110Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06764615","A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)",[20],"2026-08-26T02:16:54.876240Z","2026-07-05T05:32:16.692642Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07680283","Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD",[],"2026-08-26T02:19:29.922117Z","2026-07-05T03:45:20.440651Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06405087","A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)",[12],"2026-08-26T02:17:26.640202Z","2026-07-05T03:45:20.234943Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT07556718","Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease",[20],"2026-08-26T02:17:39.048487Z","2026-05-13T02:55:06.723519Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT07499232","A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease",[12],"2026-08-26T02:18:53.782384Z","2026-05-13T02:55:06.710333Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":58,"content_modified":59},"NCT05781152","Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease",[57],"Phase 4","2026-08-26T02:15:54.846520Z","2026-05-05T02:43:29.730720Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06819891","A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease",[12],"2026-08-26T02:17:43.321968Z","2026-05-05T02:43:29.584267Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT07337902","Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)",[],"2026-08-26T02:18:14.396999Z","2026-05-05T02:43:29.524739Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06430801","A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)",[12],"2026-08-26T02:19:12.219640Z","2026-05-05T02:43:29.509144Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT06819878","A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease",[12],"2026-08-26T02:17:06.985283Z","2026-05-05T02:43:29.396991Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT06045754","A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease",[57],"2026-08-26T02:18:43.501109Z","2026-05-05T02:43:29.385139Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT06976853","Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease",[20],"2026-08-26T02:18:54.586325Z","2026-05-05T02:43:29.349617Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":101,"content_modified":102},"NCT04224558","Stem Cell Transplantation in Crohn's Disease",[100],"Phase 1\u002FPhase 2","2026-08-26T02:18:56.409949Z","2026-05-05T02:43:29.336605Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT06721962","Treatment of Moderate to Severe Refractory Crohn's Disease",[100],"2026-08-26T02:16:00.194860Z","2026-05-05T02:43:29.155582Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT07483073","A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease",[20],"2026-08-26T02:16:20.336282Z","2026-05-05T02:43:29.056338Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":33,"content_modified":119},"NCT06274554","Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease",[12],"2026-05-05T02:43:29.040162Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":27,"content_modified":124},"NCT07184931","An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease",[12],"2026-05-05T02:43:28.643690Z",{"nct_id":126,"title":127,"phases":128,"status":13,"updated_at":129,"content_modified":130},"NCT05923073","A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease",[12],"2026-08-26T02:15:49.658025Z","2026-05-05T02:43:28.629301Z",{"nct_id":132,"title":133,"phases":134,"status":13,"updated_at":135,"content_modified":136},"NCT05849012","A Pilot Study Examining Low Sulfur Diet as Treatment for Persistent Symptoms in Quiescent Crohn's Disease",[],"2026-08-26T02:15:34.659160Z","2026-05-05T02:43:28.560598Z",{"nct_id":138,"title":139,"phases":140,"status":13,"updated_at":141,"content_modified":142},"NCT06257706","VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease",[57],"2026-08-26T02:16:06.684983Z","2026-05-05T02:43:28.534645Z",{"nct_id":144,"title":145,"phases":146,"status":13,"updated_at":147,"content_modified":148},"NCT00692939","Autologous Stem Cell Transplantation for Crohn's Disease",[100],"2026-08-26T02:19:08.862440Z","2026-05-05T02:43:28.503735Z",{"nct_id":150,"title":151,"phases":152,"status":13,"updated_at":153,"content_modified":154},"NCT06332534","Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease",[12],"2026-08-26T02:17:05.997056Z","2026-05-05T02:43:28.302494Z",{"nct_id":156,"title":157,"phases":158,"status":13,"updated_at":159,"content_modified":160},"NCT06548542","Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease",[20],"2026-08-26T02:18:21.216897Z","2026-05-05T02:43:28.283680Z",{"nct_id":162,"title":163,"phases":164,"status":13,"updated_at":165,"content_modified":166},"NCT04844606","A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)",[12],"2026-08-26T02:15:18.897219Z","2026-05-05T02:43:28.183268Z",{"nct_id":168,"title":169,"phases":170,"status":13,"updated_at":171,"content_modified":172},"NCT07483099","A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease",[20],"2026-08-26T02:18:11.042248Z","2026-05-05T02:43:28.131489Z",{"nct_id":174,"title":175,"phases":176,"status":13,"updated_at":177,"content_modified":178},"NCT06512597","Behavioral Therapy for Crohn's Disease",[],"2026-08-26T02:17:19.710918Z","2026-05-05T02:43:27.993126Z",{"nct_id":180,"title":181,"phases":182,"status":13,"updated_at":183,"content_modified":184},"NCT06647615","A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease",[],"2026-08-26T02:16:54.044282Z","2026-05-05T02:43:27.976742Z",{"nct_id":186,"title":187,"phases":188,"status":13,"updated_at":189,"content_modified":190},"NCT06100289","A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease",[12],"2026-08-26T02:16:05.813655Z","2026-05-05T02:43:27.857973Z",{"nct_id":192,"title":193,"phases":194,"status":13,"updated_at":195,"content_modified":196},"NCT06651281","Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)",[12],"2026-08-26T02:15:36.077529Z","2026-05-05T02:43:27.830906Z",{"nct_id":198,"title":199,"phases":200,"status":13,"updated_at":202,"content_modified":203},"NCT05660746","Precise Infliximab Exposure and Pharmacodynamic Control",[201],"Phase 2\u002FPhase 3","2026-08-26T02:16:16.995720Z","2026-05-05T02:43:27.751187Z",{"nct_id":205,"title":206,"phases":207,"status":13,"updated_at":208,"content_modified":209},"NCT06456593","Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease",[20],"2026-08-26T02:17:39.857430Z","2026-05-05T02:43:27.664581Z",{"nct_id":211,"title":212,"phases":213,"status":13,"updated_at":214,"content_modified":215},"NCT07184944","A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease",[12],"2026-08-26T02:19:30.857183Z","2026-05-05T02:43:27.474445Z",{"nct_id":217,"title":218,"phases":219,"status":13,"updated_at":220,"content_modified":221},"NCT03847467","Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy",[100],"2026-08-03T03:42:33.588058Z","2026-05-05T02:43:27.445827Z",{"nct_id":223,"title":224,"phases":225,"status":13,"updated_at":226,"content_modified":227},"NCT06637631","A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.",[20],"2026-08-26T02:18:03.638950Z","2026-05-05T02:43:27.393797Z",{"nct_id":229,"title":230,"phases":231,"status":13,"updated_at":232,"content_modified":233},"NCT04779320","A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)",[12],"2026-08-26T02:16:57.705506Z","2026-05-05T02:43:27.275815Z",{"nct_id":235,"title":236,"phases":237,"status":13,"updated_at":238,"content_modified":239},"NCT05995353","A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease",[12],"2026-08-26T02:19:17.380174Z","2026-05-05T02:43:27.133352Z",{"nct_id":241,"title":242,"phases":243,"status":13,"updated_at":244,"content_modified":245},"NCT06233461","A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease",[20],"2026-08-26T02:15:27.567165Z","2026-05-05T02:43:27.132262Z",{"nct_id":247,"title":248,"phases":249,"status":13,"updated_at":250,"content_modified":251},"NCT06958536","A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease",[20],"2026-08-26T02:17:24.721169Z","2026-05-05T02:43:27.071512Z",{"nct_id":253,"title":254,"phases":255,"status":13,"updated_at":256,"content_modified":257},"NCT06216899","Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial",[],"2026-08-26T02:16:44.178623Z","2026-05-05T02:43:27.053899Z",{"nct_id":259,"title":260,"phases":261,"status":13,"updated_at":262,"content_modified":263},"NCT06581328","A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting",[57],"2026-08-26T02:19:09.651016Z","2026-05-05T02:43:26.767286Z",{"nct_id":265,"title":266,"phases":267,"status":13,"updated_at":202,"content_modified":268},"NCT04263831","Low Dose IL-2 for the Treatment of Crohn's Disease",[100],"2026-05-05T02:43:26.693743Z",{"nct_id":270,"title":271,"phases":272,"status":13,"updated_at":273,"content_modified":274},"NCT05509777","A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease",[12],"2026-08-26T02:16:09.452956Z","2026-05-05T02:43:26.687431Z",{"nct_id":276,"title":277,"phases":278,"status":13,"updated_at":279,"content_modified":280},"NCT06226883","A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease",[20],"2026-08-26T02:15:31.806698Z","2026-05-05T02:43:26.677033Z",{"nct_id":282,"title":283,"phases":284,"status":13,"updated_at":285,"content_modified":286},"NCT03219359","Autologous Stem Cell Transplant for Crohn's Disease",[20],"2026-08-26T02:15:30.699880Z","2026-05-05T02:43:26.676255Z",{"nct_id":288,"title":289,"phases":290,"status":13,"updated_at":153,"content_modified":291},"NCT05973500","Effect of Mediterranean Diet in Inflammatory Bowel Disease",[],"2026-05-05T02:35:31.774822Z",{"nct_id":293,"title":294,"phases":295,"status":13,"updated_at":296,"content_modified":297},"NCT05442567","A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)",[12],"2026-08-26T02:15:17.167444Z","2026-05-05T02:35:31.622695Z",{"nct_id":299,"title":300,"phases":301,"status":13,"updated_at":302,"content_modified":303},"NCT07077746","HB-adMSCs for the Treatment of Crohn's Disease",[20],"2026-08-26T02:18:58.958025Z","2026-04-29T02:57:57.067645Z",{"nct_id":305,"title":306,"phases":307,"status":13,"updated_at":238,"content_modified":308},"NCT07196722","A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease",[201],"2026-04-29T02:57:57.066917Z",[],[311,315,319,323,327,331,335,339,343,347,351,354,358,361,365,368,372,376,379,383,386,390,393,397],{"state":312,"count":313,"slug":314},"New York",49,"new-york",{"state":316,"count":317,"slug":318},"California",48,"california",{"state":320,"count":321,"slug":322},"Texas",41,"texas",{"state":324,"count":325,"slug":326},"Massachusetts",40,"massachusetts",{"state":328,"count":329,"slug":330},"Florida",39,"florida",{"state":332,"count":333,"slug":334},"Ohio",36,"ohio",{"state":336,"count":337,"slug":338},"Pennsylvania",35,"pennsylvania",{"state":340,"count":341,"slug":342},"Illinois",29,"illinois",{"state":344,"count":345,"slug":346},"North Carolina",28,"north-carolina",{"state":348,"count":349,"slug":350},"Georgia",26,"georgia",{"state":352,"count":349,"slug":353},"Michigan","michigan",{"state":355,"count":356,"slug":357},"Arizona",23,"arizona",{"state":359,"count":356,"slug":360},"Missouri","missouri",{"state":362,"count":363,"slug":364},"Colorado",22,"colorado",{"state":366,"count":363,"slug":367},"Washington","washington",{"state":369,"count":370,"slug":371},"Maryland",21,"maryland",{"state":373,"count":374,"slug":375},"Connecticut",19,"connecticut",{"state":377,"count":374,"slug":378},"South Carolina","south-carolina",{"state":380,"count":381,"slug":382},"Indiana",18,"indiana",{"state":384,"count":381,"slug":385},"Virginia","virginia",{"state":387,"count":388,"slug":389},"Minnesota",16,"minnesota",{"state":391,"count":388,"slug":392},"Rhode Island","rhode-island",{"state":394,"count":395,"slug":396},"Kentucky",15,"kentucky",{"state":398,"count":399,"slug":400},"Louisiana",14,"louisiana"]